Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$267,743
-$43,272 QoQ
Shares Held
1,412
-10.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,087
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. AZN ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,905 | $17,842,534 | |
| 2 | LLY |
ELI LILLY & Co
|
12,084 | $14,493,913 | |
| 3 | JNJ |
Johnson & Johnson
|
23,321 | $5,922,834 | |
| 4 | NVO |
Novo Nordisk A S
|
113,575 | $5,444,785 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,742 | $346,424 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
1,412 | $267,743 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,014 | $258,799 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,743 | 1,412 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $311,015 | 1,577 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||